Fortive Corporation Research Report from a Long-Term Business Owner's Perspective

Industry and Competitive Landscape

【Fact】In its 10-K, Fortive places its continuing operations in an environment that is "globalized, technologically evolving, increasingly regulated, and highly fragmented in competition," and stresses that long-term growth depends on innovation, sales efficiency, cost improvement, talent retention, and acquisition integration. This is not a naturally monopolistic industry. It is more like a portfolio of niches: industrial safety and testing, asset and facility software, hospital sterilization, and clinical efficiency tools. The advantage is diversified end demand; the drawback is that one does not see the strong network effects of a single platform company.

【Inference】If industry stages are grouped broadly, I would put Fortive in "structural growth sub-sectors within mature industries." The reason is that needs such as industrial maintenance, compliance and safety, asset management, hospital sterilization, and clinical productivity are not high-speed explosive categories, but they will not disappear over the long run and are readily supported by regulation, efficiency improvement, digital transformation, and rising labor costs. The real risk is not that "the industry is disrupted overnight," but that demand cadence can be shaped by the macro environment, especially government budgets, hospital capital spending, and cross-border trade policy. Management already stated in mid-2025 that uncertainty around tariff-related pricing, healthcare policy, and government spending policy created pressure near the end of the second quarter.

【Fact】From a capital-market perspective, the most common comparable companies are Roper, AMETEK, and IDEX. They are not one-for-one operating peers of Fortive, but all belong to the category of industrial technology platforms with higher technical content, acquisition-driven models, and cash-flow orientation. As of May 29, 2026, Roper, AMETEK, and IDEX had market capitalizations of about $34.05 billion, $51.91 billion, and $15.69 billion, respectively. In terms of "corporate profile," Fortive is now clearly closer to this kind of compound industrial technology platform than to traditional capital-intensive equipment manufacturers.

【View】I rate the industry's attractiveness at 4/5. This is not an "invincible industry," but it is a good arena with stable long-term demand, customers willing to pay for efficiency and compliance, and cash-flow quality that is usually better than traditional manufacturing. Rather than calling it "an excellent company in a poor industry," it is more accurate to call it "a high-quality platform company in decent industrial and healthcare workflow industries." The caution to retain is that it is not a company that monopolizes an industry's profit pool through a single platform, so an excessive valuation is not easy to absorb through absolute competitive advantage.

Moat, Management, and Capital Allocation

Moat Analysis

【Fact】Three ideas recur in Fortive's official language: iconic brands, leading positions, and the Fortive Business System. The 10-K describes FBS as the core mechanism for continuous improvement across the portfolio. The Investor Day also presented "about 50% recurring revenue," "strong free cash flow," and "focus on highly attractive markets" as core traits of the new Fortive. Combining end markets and channel structure, I think its moat lies not in network effects, but in brand/product credibility + workflow embedding + sales and service capability + operating methodology.

Breaking down the moat: Brand advantage: present, but mainly in B2B/professional brands, not consumer brands. The value of businesses such as Fluke, Industrial Scientific, Accruent, ServiceChannel, and ASP lies in customers treating them as critical workflow tools, not commodities that can be casually replaced by a cheaper option.

Cost advantage: limited. Fortive is not like the lowest-cost commodity manufacturer. It is more like a company that earns through high gross margins, high value-added products, and software and service attachment. From 2023 to 2025, GAAP gross margin was broadly stable at 63%-64%, and CapEx represented only about 2%-3% of revenue. This shows that it does have an asset-light advantage, but this is not the typical cost moat of "scale compressing cost."

Scale advantage: moderate. Scale helps R&D, sales networks, acquisition integration, and back-office efficiency, but many of its sub-markets remain fragmented and competitive, falling short of "winner takes all."

Network effects: weak overall. In local products such as facility and clinical software, data accumulation and process embedding may create local network and ecosystem advantages, but for the group overall, network effects are not the primary driver.

Switching costs: moderately high. In scenarios such as healthcare sterilization, instrument tracking, facility and asset workflows, and industrial safety compliance, once a system enters daily processes, switching brings validation, training, downtime, compliance, and data migration costs. Switching costs are therefore meaningfully higher than in ordinary equipment procurement.

Channel advantage: present. Only about $168 million came from distributors in 2024, while direct sales were about $3.913 billion, indicating that the company controls more end-customer relationships. That is more resilient than a business model highly dependent on agents.

Patents, licenses, and regulatory barriers: present locally. Products related to healthcare, radiation detection, safety, and compliance naturally require certification, validation, and accumulated reliability. These barriers are usually not as steep as pharmaceutical patents, but they are enough to increase replication difficulty.

Data advantage: present locally, not strong at the group level. Software and connected workflow businesses accumulate data through use, but there is currently insufficient evidence that Fortive has formed a "data monopoly."

Culture and operating capability: clearly present. FBS is the "soft moat" that I think deserves the most serious attention. It at least explains why the company has been able to produce high cash flow over the long term with relatively light capital spending.

Overall, I rate Fortive's moat strength at 3/5. The reason is not that it is poor, but that the moat is more about the compounding of "systematic operations and a multi-brand portfolio" than about any single business possessing an extremely strong, deep, and wide quasi-monopoly barrier. I would rate the moat condition as stable to slightly widening: a rising recurring mix and higher software and service weight are positive signs, but the new Fortive's independent operating history is still too short to justify a higher score for now.

Is Management Trustworthy, and Is Capital Allocation Rational?

【Fact】When the separation was completed in June 2025, long-serving CEO James Lico retired, and Olumide Soroye became Fortive's President and CEO and joined the board. In other words, what you are evaluating today is not "the old Fortive team fully continuing in the old portfolio," but a more focused portfolio under a new CEO officially at the helm. From the beginning, management listed "accelerating earnings growth, disciplined capital allocation, and building investor trust" as three pillars.

【Fact】The capital allocation actions are very clear. In 2025, the company used about $1.61 billion of cash for repurchases, and the statement of changes in equity showed common stock repurchases at cost of about $1.618 billion. In Q1 2026, it repurchased another about $500 million, or about 9 million shares. Based on the disclosed numbers, the approximate average repurchase price was about $53.2 per share for full-year 2025 and about $55.6 per share for Q1 2026, both below the current share price of about $58.3. At least with hindsight, these were not obviously impulsive high-price buybacks. At the same time, the company continued paying dividends, with common stock dividends of about $92.2 million in 2025.

【Fact】On governance, publicly searchable proxy excerpts confirm that the company has a compensation clawback policy, has established stock ownership requirements for directors and executives, and has an absolute prohibition on pledging. These designs are positive. But because the full 2026 Proxy text could not be fully opened under the search conditions for this report, I cannot rigorously verify the new CEO's and key executives' actual shareholdings and ownership-compliance progress in this report. The evidence for whether interests are sufficiently aligned with shareholders is therefore more institutional than balance-based.

【View】My score for management and capital allocation is 3/5. The reasons are: First, the direction is right: the separation made the company simpler, repurchase prices do not look excessive for now, the dividend is maintained, and management has written "investor trust" into the strategy. Second, empirical proof is insufficient: the new CEO has formally been in charge for less than a year, and the new capital allocation framework has not yet shown through-the-cycle data proving it is superior to "ordinary acquisition + repurchase" behavior. Third, accounting and capital discipline still need close watching: goodwill and intangible assets are high, showing a heavy acquisition history. If future high-priced acquisitions occur, financial returns could be easily diluted.

Financial Quality and Owner Earnings

Key Financial Metrics

To improve comparability, the 2019-2024 data in the table below use the supplemental basis disclosed by the company in June 2025 that assumes Ralliant had been a discontinued operation. The 2025 data use actual post-separation continuing operations. The purpose is to show a historical trajectory closer to the "new Fortive," rather than mixing in businesses that have already been separated.

Revenue, net income, adjusted EBITDA, and free cash flow for 2019-2024 in the table come from the company's June 2025 supplemental financial data. 2025 revenue and net income from continuing operations come from the 2025 10-K, while adjusted EBITDA and free cash flow come from the full-year 2025 earnings disclosure. Net income in 2020-2021 was affected by debt extinguishment, Vontier-related gains/losses, and other items, making comparability weaker and unsuitable for linear extrapolation.

【Fact】On the basis above, revenue CAGR from 2019 to 2025 was about 7.1%, and free cash flow CAGR was about 9.6%. From 2023 to 2025, GAAP gross margin was roughly 63%-64%, GAAP operating margin rose from 14.7% to 17.3%, and net margin from continuing operations rose from 10.4% to 12.8%. This set of data shows that post-separation Fortive is not exchanging large capital investment for growth. Instead, under a relatively asset-light structure, it has converted more revenue into profit and cash.

【Fact】In 2025, operating cash flow from continuing operations was about $1.036 billion, capital expenditures were about $105 million, and GAAP free cash flow was therefore about $931 million. In Q1 2026, operating cash flow was about $220 million, and free cash flow was about $194 million. Free cash flow in 2023-2025 was about 185%, 195%, and 175% of net income from continuing operations, respectively, far above GAAP net income. This is clearly not a typical case of "inflated profit and weak cash."

【Fact】The core reason for this "cash far above net income" is high non-cash expense: amortization of about $368 million, depreciation of about $70.1 million, and stock-based compensation of about $117 million in 2025. Most amortization came from intangible assets created by prior acquisitions. In other words, Fortive's issue is not "cash flow failing to keep up with earnings," but "GAAP earnings being meaningfully depressed by acquisition accounting, and how investors should treat those non-cash amortization charges." This is exactly what Owner Earnings analysis needs to address.

【Fact】On the balance sheet, cash at year-end 2025 was about $376 million, and total debt was about $3.206 billion. Goodwill was about $7.298 billion, and other intangible assets, net, were about $2.188 billion. Together they totaled about $9.487 billion, accounting for the vast majority of total assets of $11.738 billion. At the end of Q1 2026, the company's long-term debt was about $2.589 billion, cash was about $356 million, and share count had fallen to 305.6 million shares after continued repurchases. This means that, on one hand, leverage is not out of control, and 2025 EBIT/interest coverage was still about 6x. On the other hand, the "hardness" of book assets is weak. If future acquisitions are mishandled, impairment risk is real.

【Fact】Working capital did not show obvious deterioration. In 2025, changes in accounts receivable brought about a $8.7 million cash inflow, inventories caused about a $20.0 million cash outflow, accounts payable brought about a $12.4 million cash inflow, prepaid and other assets caused about a $15.6 million cash outflow, and accrued expenses and other liabilities brought about a $13.0 million cash inflow. Overall, the drag from working capital on cash flow was light. Inventory rose from $270 million at year-end 2024 to $292 million at year-end 2025, and was roughly $285 million in Q1 2026, with no sign of uncontrolled buildup. CapEx intensity has also been low for a long time, with 2025 CapEx/revenue of about 2.5%.

【Judgment】If looking only at financial quality, I would state it plainly: Fortive's earnings are real cash earnings, but GAAP earnings are depressed by acquisition amortization and some non-cash expenses. That does not mean investors can blindly assign a high valuation to "adjusted earnings," because amortization from acquisitions is non-cash but corresponds to real historical purchase prices and future capital allocation responsibility. There are no obvious signs of accounting fraud or earnings manipulation. What truly requires attention is the common risk in acquisition-driven companies that non-GAAP metrics can look too attractive.

Owner Earnings Analysis

【Method】I use a relatively conservative Owner Earnings approach:

• Owner Earnings floor: directly use free cash flow from continuing operations, about $931 million.

• Owner Earnings midpoint: considering Fortive's asset-light business, the growth component within total CapEx, and nearly neutral working-capital changes in 2025, I estimate maintenance capital expenditures at $85-100 million, corresponding to a midpoint Owner Earnings range of about $930-950 million.

• Conservative treatment of stock-based compensation: I do not treat stock-based compensation as a free profit source that can simply be added back. Instead, I absorb its economic cost through a lower valuation range and a more cautious buy price. This treatment is imperfect, but it is more conservative than simply adding back all non-cash items.

【Fact + Inference】Using 2025 data: net income from continuing operations was $533 million. Adding back depreciation of $70 million and amortization of $368 million significantly lifts cash earning power. Net working-capital consumption in 2025 was small. Capital expenditures were about $105 million. Therefore, it is reasonable to treat 2025 free cash flow from continuing operations of $931 million as a conservative proxy for Owner Earnings. If one further believes that a small portion of CapEx was growth CapEx, the Owner Earnings midpoint can be around $950 million.

【Conclusion】At the current market capitalization of about $18.24 billion, Fortive's P/Owner Earnings is roughly 19-20x. Based on the current share price of about $58.32 and 305.6 million shares at the end of Q1 2026, Owner Earnings per share are roughly $3.0-3.1. This is not cheap-stock pricing. It looks more like a compound industrial technology company of decent quality trading near fair value.

Valuation, Margin of Safety, and Opportunity Cost

Intrinsic Value Estimate

Owner Earnings Discount Method

【Assumptions】The following valuations all start from 2025 midpoint Owner Earnings of $950 million, use 305.6 million shares at the end of Q1 2026 as the approximate current share count, and apply a 10-year cash-flow discount model. This is an equity valuation, not an enterprise value valuation.

• Conservative case: OE annual growth of 4% over the next 10 years, discount rate of 9%, and perpetual growth of 2.5%.

• Base case: OE annual growth of 6% over the next 10 years, discount rate of 8.5%, and perpetual growth of 3%.

• Bull case: OE annual growth of 8% over the next 10 years, discount rate of 8%, and perpetual growth of 3.5%. These growth rates are not aggressive. Considering revenue CAGR of about 7.1% and free cash flow CAGR of about 9.6% from 2019 to 2025, they are still "conservative to base" assumptions.

The figures above are the author's calculations based on the company's disclosed Owner Earnings inputs, share count, and discount assumptions. They are not company guidance. The main sources supporting the inputs are the 2025 10-K, full-year 2025 earnings disclosure, Q1 2026 share-count data, and latest share price.

My practical conclusion is not to simply take the midpoint, but to apply conservative layering:

• Conservative intrinsic value range: $50-60 per share

• Reasonable intrinsic value range: $65-80 per share

• Bullish intrinsic value range: $90-110 per share Therefore, at the current $58.32, Fortive is not obviously undervalued. It is closer to the range of "near the conservative value and below the base value." For conservative investors, that usually means "track it, no need to chase."

Relative Valuation Method

【Fact】Based on the current share price and 2025 data, Fortive's main valuation metrics are roughly as follows:

• P/E (market-displayed TTM GAAP): about 34.9x

• P/B: about 2.8x

• P/FCF: about 19.6x

• EV/adjusted EBITDA: about 17.1x (rough estimate using year-end 2025 debt/cash) These numbers show that Fortive looks expensive using GAAP earnings. Using free cash flow and EBITDA, it sits in the position of "a good company at a reasonable-to-somewhat-expensive price," not a "deep value stock."

The market capitalizations and P/E figures in the table come from latest market data. Roper, AMETEK, and IDEX's FCF/EBITDA/margins are based on each company's official FY2025 results disclosures. Fortive is indeed less expensive than AMETEK and IDEX, but it does not have an advantage over Roper. Therefore, one cannot conclude that Fortive is cheap simply because "most quality industrial technology stocks are expensive."

Asset or Liquidation Value Method

【Fact】Fortive's shareholders' equity at year-end 2025 was about $6.461 billion, while goodwill was about $7.298 billion and other intangible assets, net, were about $2.188 billion. In other words, tangible net assets were negative. This means that if you evaluate it using a "discounted book value + liquidation" approach, the result is not a cushion but a warning: this is a company that must realize value through future cash flow, not one strongly supported by tangible assets.

【Conclusion】The role of the asset method for Fortive is not to tell you how much it is worth, but to tell you not to treat it as a PB-style investment. My valuation conclusion must therefore rely more on Owner Earnings and cash flow than book net assets. For conservative investors, this naturally raises the required purchase-price discipline.

Margin of Safety and Opportunity Cost

【Judgment】The biggest issue with the current share price is not that it is "absurdly expensive," but that the margin of safety is not thick enough. If you believe the base case, $58 is not bad. But if you operate under the conservative case, which is exactly how a balanced but somewhat conservative investor should act, the current price is only hovering near conservative intrinsic value. In other words, if growth is slightly below expectations, margins give back, or the market compresses valuation multiples for acquisition-driven platforms, you do not have a very thick buffer.

I think the three most fragile assumptions in the valuation are: First, whether "about 50% recurring revenue" can steadily translate into higher, more sustainable growth and pricing power; Second, whether new management will maintain disciplined capital allocation instead of returning to the impulse of expensive acquisitions; Third, whether AHS and government/hospital-related demand will fall short of the medium-term framework amid policy disruption. If any one of these assumptions fails, the conservative valuation would be revised downward.

If comparing Fortive with alternative opportunities, I would view it this way:

• Compared with the strongest platform peers: Based on official 2025 data, Roper has stronger FCF and EBITDA quality, and its P/FCF is actually lower. Fortive does not have an overwhelming relative advantage.

• Compared with broad indices: Fortive's own performance chart in its 2025 10-K shows that shareholder total return over the past several years has clearly lagged the S&P 500 and S&P 500 Industrials. That does not automatically mean it will underperform in the future, but it at least shows the market has not treated it as an obvious winner.

• Compared with the risk-free rate: On May 29, the U.S. 10-year Treasury yield was about 4.45%. If your conservative expected annualized return for Fortive is only around 4%-5%, it offers almost insufficient risk compensation. Only in the base case does Fortive start to look more worth bearing volatility and execution risk than Treasury bonds.

Therefore, my price framework is:

• Ideal buy price range: $45-54

• Acceptable holding price range: $54-75

• Clearly overvalued price range: above $85 The logic of this range is not magical precision. It combines "conservative intrinsic value + required margin of safety + above-average company quality." The current $58 is not at a "must sell" level, but it is also not at a "buy on sight" level.

Risks, Counterarguments, and Final Recommendation

Most Important Risks and the Strongest Bear Case

The Fortive risks that deserve the most serious attention are not short-term share-price fluctuations, but the following kinds of permanent capital loss risks.

The key basis for these risks comes from the company's 10-K disclosures on competition, debt, impairment, and macro factors, as well as public management comments on 2025-2026 demand pressure and refinancing arrangements.

The strongest bear case is roughly this: Fortive may be only "a set of reasonably good niche industrial and healthcare assets," rather than a set of exceptional assets capable of continuously widening the moat over the long term. The claimed roughly 50% recurring revenue may not automatically translate into higher real pricing power. Although low GAAP earnings partly reflect amortization, that also reminds you that historical growth was bought with money. More importantly, the current valuation has already priced in a meaningful portion of the hope that "the new Fortive will be better." If core growth remains only in the low single digits over the next three to four quarters and capital allocation relies heavily on buybacks to support per-share metrics, buyers today may end up owning an "excellent company at an ordinary price."

What facts would overturn the current investment judgment? If the following occur, I would admit that my originally positive "good business" judgment had been impaired: First, core growth is clearly below 3% for multiple consecutive quarters and adjusted EBITDA margin cannot hold the current high level; Second, free cash flow from continuing operations falls below $800 million for reasons that are not one-time; Third, net debt/EBITDA rises above 3x alongside expensive acquisitions; Fourth, a large goodwill/intangible asset impairment appears; Fifth, management again puts large-scale M&A ahead of growth in per-share intrinsic value. These thresholds are not company guidance. They are "long-term owner warning lines" set based on current revenue, margins, cash flow, and leverage levels.

Investment Checklist

The core meaning of this checklist is simple: the business itself is more reassuring than the price; the price is more hesitation-inducing than the business. That is the fundamental reason for "Watch" rather than "Buy."

Final Investment Conclusion

【Final Rating】 Watch

【One-Sentence Investment Thesis】 Fortive is a post-separation, more focused industrial/healthcare workflow platform with strong cash-flow quality and a moderate moat, but the current price does not yet give conservative long-term investors enough margin of safety.

【Core Bull Points】

• After the separation, the business is simpler and focused on the two major segments of IOS and AHS, making it easier for long-term owners to understand.

• Recurring revenue is about 50% of the mix, the business is embedded in critical workflows, and demand stickiness is higher than ordinary equipment sales.

• Free cash flow is strong, about $931 million in 2025, CapEx intensity is low, and cash generation is solid.

• Buyback execution was substantial in 2025 and Q1 2026, and the average repurchase prices do not look aggressive in hindsight.

• FBS, as a cross-portfolio operating system, is indeed one of the few "soft moats" worth tracking over the long term.

【Core Bear Points】

• The valuation is not cheap. The current price looks closer to "near fair value" than to an "undervalued price."

• Goodwill and intangible assets are extremely high, tangible net assets are negative, and there is little asset safety cushion.

• The new CEO has been in charge for only a short time, and capital allocation and acquisition discipline still need through-the-cycle validation.

• Healthcare, government, and trade policy have been explicitly listed by management as sources of demand disruption.

• The company uses many non-GAAP metrics. If investors are not cautious enough about amortization and equity compensation, they can easily overestimate the true cheapness.

【Key Assumptions】

• Owner Earnings can remain above $900 million over the long term and grow at a mid-single-digit rate;

• Adjusted EBITDA margin can broadly stay in the high 20% range;

• Capital allocation will focus mainly on small and mid-sized acquisitions, repurchases, and dividends, rather than restarting expensive large-scale M&A;

• 2026 refinancing will not materially erode free-cash-flow quality.

【Fair Buy Price】 $45-54 per share. The basis is a 10%-20% cushion to conservative intrinsic value, or a more acceptable margin of safety against base-case intrinsic value.

【Target Holding Period】 More than 10 years. This is a business better suited to "compounder tracking" and not suited to using quarterly volatility as a speculative logic.

【Expected Annualized Return】

• Conservative case: 4%-5%

• Base case: 7%-9%

• Bull case: 10%-12% These returns do not come from an assumption of short-term valuation repair, but from a combination of Owner Earnings growth and long-term exit valuation. At the current price, its compensation for risk is not especially attractive.

【Maximum Loss Risk】 In a permanent loss scenario of "growth misses expectations + margins retreat + valuation multiple compresses," a decline to $32-39 is not unimaginable, corresponding to about -33% to -45% from the current price. This is not a crash assumption. It is an inference based on free cash flow falling to $700-800 million and the market assigning only a 14-15x cash-flow multiple.

【Tracking Indicators】 Key indicators to track continuously include:

• Core revenue growth rate;

• Adjusted EBITDA margin;

• Free cash flow from continuing operations and its conversion ratio versus adjusted earnings;

• Net debt/EBITDA;

• Repurchase amount, average repurchase price, and share-count changes;

• AHS segment revenue and margin recovery;

• Recurring revenue share and software/service renewal performance;

• Goodwill / intangible asset impairment signals;

• Valuation and integration progress of any major single acquisition;

• Whether management disclosures continue to emphasize "growth in per-share intrinsic value" rather than pure scale expansion.

【Signals That Trigger Reassessment】

• Core growth clearly stalls for multiple quarters;

• Adjusted EBITDA margin falls clearly below the mid-to-high 20% range;

• Cash flow remains weaker than net income and adjusted earnings;

• Interest burden rises materially after refinancing;

• A large impairment or expensive acquisition occurs;

• Management repurchases shares in a clearly overvalued range.

【Final Recommendation】 Put calmly, Fortive deserves a place on a long-term watchlist, but right now it is more a case of "wait for the price" than "chase the price." If you already hold shares at a lower cost basis, the company's cash-flow quality and business understandability are enough to support continued holding while observing whether new management delivers on its strategy. If you are opening a new position, given your "balanced but somewhat conservative" risk preference, I would be more patient and wait for a thicker margin of safety, rather than accept an ordinary price simply because it is a good company.

Open Questions and Limitations

This report still has three limitations that should be stated clearly. First, the full 2026 Proxy text could not be fully opened under the search conditions for this report, so executives' actual shareholdings and ownership-compliance progress could not be fully verified. I can only confirm that the company has clawback, stock ownership requirements, and anti-pledging mechanisms. Second, real-time comparable metrics for peer EV/EBITDA are limited by the availability of net-debt snapshots, so in relative valuation I place greater weight on P/E, P/FCF, margins, and cash-flow quality. Third, Fortive's economic boundaries changed after the 2025 separation of Ralliant, so historical data must be viewed using the company's supplemental disclosure basis and cannot mechanically inherit the pre-separation old Fortive narrative.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.